NASDAQ
TOIIW

The Oncology Institute Inc

Medical Care Facilities
Healthcare

Prices are adjusted according to historical splits.

The Oncology Institute Inc Stock Price

Vitals

Today's Low:
$0.1328
Today's High:
$0.1415
Open Price:
$0.14
52W Low:
$0.022
52W High:
$1.18
Prev. Close:
$0.1352
Volume:
9854

Company Statistics

Market Cap.:
$0
Book Value:
Revenue TTM:
$194.64 million
Operating Margin TTM:
-4.4%
Gross Profit TTM:
$0
Profit Margin:
-1.69%
Return on Assets TTM:
0%
Return on Equity TTM:
0%

Company Profile

The Oncology Institute Inc had its IPO on 2020-06-04 under the ticker symbol TOIIW.

The company operates in the Healthcare sector and Medical Care Facilities industry. The Oncology Institute Inc has a staff strength of 553 employees.

Stock update

Shares of The Oncology Institute Inc opened at $0.14 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.13 - $0.14, and closed at $0.13.

This is a -1.78% slip from the previous day's closing price.

A total volume of 9,854 shares were traded at the close of the day’s session.

In the last one week, shares of The Oncology Institute Inc have increased by +72.24%.

The Oncology Institute Inc's Key Ratios

The Oncology Institute Inc has a market cap of $0, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months The Oncology Institute Inc’s revenue was $194.64 million with a gross profit of $0 and an EBITDA of $-5409041. The EBITDA ratio measures The Oncology Institute Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, The Oncology Institute Inc’s operating margin was -4.4% while its return on assets stood at 0% with a return of equity of 0%.

In Q2, The Oncology Institute Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 5.4%.

The Oncology Institute Inc’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $-602.087 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into The Oncology Institute Inc’s profitability.

The Oncology Institute Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

The Oncology Institute Inc stock pays annual dividends of $ per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$229.96 million
Total Liabilities
$33.51 million
Operating Cash Flow
$0
Capital Expenditure
$937000
Dividend Payout Ratio
0%

The Oncology Institute Inc ended 2024 with $229.96 million in total assets and $0 in total liabilities. Its intangible assets were valued at $229.96 million while shareholder equity stood at $84.72 million.

The Oncology Institute Inc ended 2024 with $0 in deferred long-term liabilities, $33.51 million in other current liabilities, 7000.00 in common stock, $-109977000.00 in retained earnings and $7.23 million in goodwill. Its cash balance stood at $28.89 million and cash and short-term investments were $39.18 million. The company’s total short-term debt was $6,001,000 while long-term debt stood at $83.69 million.

The Oncology Institute Inc’s total current assets stands at $104.07 million while long-term investments were $58.94 million and short-term investments were $10.29 million. Its net receivables were $46.89 million compared to accounts payable of $13.12 million and inventory worth $12.17 million.

In 2024, The Oncology Institute Inc's operating cash flow was $0 while its capital expenditure stood at $937000.

Comparatively, The Oncology Institute Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$0.13
52-Week High
$1.18
52-Week Low
$0.022
Analyst Target Price
$

The Oncology Institute Inc stock is currently trading at $0.13 per share. It touched a 52-week high of $1.18 and a 52-week low of $1.18. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.07 and 200-day moving average was $0.18 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About The Oncology Institute Inc

The stock symbol (also called stock or share ticker) of The Oncology Institute Inc is TOIIW

The IPO of The Oncology Institute Inc took place on 2020-06-04

Similar Industry Stocks (Medical Care Facilities)

Last Price
Chg
Chg%
$25.22
-0.63
-2.45%
$0.89
-0.06
-6%
$486.6
-49.05
-9.16%
$6.78
-0.42
-5.83%
$7.51
-0.08
-1.05%
Kinaxis Inc (KXSCF)
$119.66
1.31
+1.11%
$10
0.03
+0.3%
$3.66
-0.08
-2.14%
$20.7
0.05
+0.24%
$29.12
0.32
+1.11%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants for cancer patients. The company was founded in 2007 and is based in Cerritos, California.

Address

18000 Studebaker Road, Cerritos, CA, United States, 90703